Literature DB >> 18027016

Long-term outcome after isolated endarterectomy of the femoral bifurcation.

Aristotelis Kechagias1, Kari Ylönen, Fausto Biancari.   

Abstract

BACKGROUND: Long-term outcome after endarterectomy of the femoral bifurcation has not been widely investigated, and the aim of this study was to assess its late results from a community-wide perspective. PATIENTS AND METHODS: Between 1983 and 2006 111 isolated endarterectomies of the common femoral artery and/or the proximal part of the superficial femoral artery or profunda femoris were performed in 90 patients at the Oulu University Hospital, Oulu, Finland. A total of 77 limbs were treated surgically for claudication and 34 others for critical limb ischemia. Angiographic findings of 100 extremities were evaluated.
RESULTS: The in-hospital mortality rate was 1.8%. The mean follow-up period was 5.9 years. At 5-, 10-, and 15-year follow-up the overall survival was 60.5%, 32.7%, and 17.6%, respectively (S.E < 0.05). A C-reactive protein value > or = 10 mg/l was predictive of poor late survival (p = 0.008). Limb salvage rates after isolated femoral endarterectomy at 5-, 10-, and 15-year follow-up were 93.7%, 93.7%, and 85.2%, respectively (S.E. < 0.08). Critical limb ischemia (p = 0.006) and current smoking (p = 0.027) were independent predictors of major lower limb amputation. A total of 41 limbs were subjected to ipsilateral vascular procedures after femoral endarterectomy, only one of which was re-endarterectomy. Freedom from any ipsilateral revascularization procedure at 5-, 10-, and 15-year follow-up was calculated at 68.0%, 50.6%, and 42.5%, respectively (S.E. < 0.08). The overall linearized rate of reintervention on the ipsilateral limb was 0.16 +/- 0.44/year. The linearized rate among patients who had any ipsilateral vascular reintervention was 0.43 +/- 0.66/year.
CONCLUSIONS: Isolated femoral endarterectomy is a rather low-risk and durable procedure. However, a significant number of reinterventions distal or proximal to the endarterectomized site can be expected in one third of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18027016     DOI: 10.1007/s00268-007-9309-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  10 in total

1.  On the depopulation of old arterial thromboses.

Authors:  J C DOS SANTOS
Journal:  Mem Acad Chir (Paris)       Date:  1947 May 28-June 4

2.  Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study.

Authors:  Fausto Biancari; Juha-Pekka Salenius; Maarit Heikkinen; Michael Luther; Kari Ylönen; Mauri Lepäntalo
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

3.  Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis.

Authors:  Tullio Palmerini; Antonio Marzocchi; Cinzia Marrozzini; Paolo Ortolani; Francesco Saia; Letizia Bacchi-Reggiani; Santo Virzì; Silvia Gianstefani; Angelo Branzi
Journal:  Circulation       Date:  2005-10-03       Impact factor: 29.690

4.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

5.  Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery.

Authors:  Olli-Pekka Kangasniemi; Fausto Biancari; Johannes Luukkonen; Sailaritta Vuorisalo; Jari Satta; Risto Pokela; Tatu Juvonen
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-08       Impact factor: 4.191

6.  Endarterectomy as the procedure of choice for atherosclerotic occlusive lesions of the common femoral artery.

Authors:  D Mukherjee; T Inahara
Journal:  Am J Surg       Date:  1989-05       Impact factor: 2.565

7.  Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.

Authors:  Jamal Barani; Jan-Ake Nilsson; Ingrid Mattiasson; Bengt Lindblad; Anders Gottsäter
Journal:  J Vasc Surg       Date:  2005-07       Impact factor: 4.268

8.  Inflow atherosclerotic disease localized to the common femoral artery: treatment and outcome.

Authors:  M E Springhorn; M Kinney; F N Littooy; C Saletta; H P Greisler
Journal:  Ann Vasc Surg       Date:  1991-05       Impact factor: 1.466

9.  [Endarteriectomy of the femoral tripod: long-term results and analysis of failure factors].

Authors:  A Cardon; S Aillet; P Jarno; K Bensalah; J Le Du; A Idrissi; Y Kerdiles
Journal:  Ann Chir       Date:  2001-10

10.  Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia.

Authors:  F J Veith; S K Gupta; K R Wengerter; J Goldsmith; S P Rivers; C W Bakal; A M Dietzek; J Cynamon; S Sprayregen; M L Gliedman
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

  10 in total
  9 in total

1.  Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes.

Authors:  Peter A Soden; Sara L Zettervall; Katie E Shean; Sarah E Deery; Jeffrey A Kalish; Christopher T Healey; Nikhil Kansal; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-09-12       Impact factor: 4.268

2.  [Diagnostics and therapy of the diabetic foot syndrome from a vascular surgery perspective].

Authors:  G Rümenapf; S Morbach; W Lang
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

3.  The Advantage of Common Femoral Endarterectomy Alone or Combined with Endovascular Treatment.

Authors:  Jun Hyung Kim; Byung Jun So; Seung Jae Byun; Kyung Yun Kim
Journal:  Vasc Specialist Int       Date:  2018-09-30

4.  Systematic Review and Proportional Meta-Analysis of Endarterectomy and Endovascular Therapy with Routine or Selective Stenting for Common Femoral Artery Atherosclerotic Disease.

Authors:  Khalid Hamid Changal; Mubbasher Ameer Syed; Tawseef Dar; Muhammad Asif Mangi; Mujeeb Abdul Sheikh
Journal:  J Interv Cardiol       Date:  2019-04-14       Impact factor: 2.279

5.  Herpes wound infection after femoral endarterectomy.

Authors:  Katherine K McMackin; Gaby Ghobrial; Mikael A Fadoul; Joseph V Lombardi
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-04-13

6.  [Diabetic foot syndrome-Part 2 : Revascularization, treatment alternatives, care structures, recurrency prophylaxis].

Authors:  G Rümenapf; S Morbach; U Rother; C Uhl; H Görtz; D Böckler; C A Behrendt; D Hochlenert; G Engels; A Hohneck; M Sigl
Journal:  Chirurg       Date:  2021-02       Impact factor: 0.955

7.  Extracellular Matrix Patches for Endarterectomy Repair.

Authors:  Keith B Allen; Joshua D Adams; Stephen F Badylak; H Edward Garrett; Nicolas J Mouawad; Steven W Oweida; Manesh Parikshak; Parvez K Sultan
Journal:  Front Cardiovasc Med       Date:  2021-02-11

Review 8.  [The vascular surgeon's role in interdisciplinary treatment of diabetic foot syndrome].

Authors:  G Rümenapf; S Dittler; S Morbach; K Amendt; A Radu
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

9.  Stent-Assisted Angioplasty (SAA) at the Level of the Common Femoral Artery Bifurcation: Long-Term Outcomes.

Authors:  H Stricker; L Spinedi; C Limoni; L Giovannacci
Journal:  Cardiovasc Intervent Radiol       Date:  2020-01-23       Impact factor: 2.740

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.